The abstract is read at the publisher; the summary is JClub's.
Two months of nicotinamide riboside (NRH) treatment in aged male mice suppresses cardiomyocyte senescence markers and improves diastolic function, linked to SIRT1 and SIRT6 activation.
- Why it matters: Cardiomyocyte senescence is linked to diastolic dysfunction and heart failure in older adults, but effective ways to delay or reverse it in the aged heart are limited.
- What they did: Young and aged mice of both sexes were compared for ventricular NAD+ metabolism, senescence markers, and cardiac function; in culture, NAD+ depletion induced senescence and NR or NRH reversed it.
- The result: In aged male mice, NR or NRH reduced senescence, hypertrophy, and fibrosis, with NRH showing more robust SIRT1 activation and SIRT6 deacetylation that enhanced DNA damage repair; aged females showed diastolic dysfunction without NAD+ decline and did not respond.
The findingWhy it mattersWhat they didThe result
AI summary of the abstract · may contain errors · not medical advice · read the paper.